Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CVS Generic Dispensing Rate Will Rise To 44.5% After Patent Expirations

Executive Summary

CVS' generic dispensing rate is expected to increase to as much as 44.5% as a number of branded drugs go off patent this year, CEO Tom Ryan said during a May 2 analysts teleconference.

You may also be interested in...

McCain/Schumer Generic Bill Would End 30-Month Stay Of Approval

The revised McCain/Schumer generic drug bill eliminates the automatic stay of approval under current patent challenge procedures.

PhRMA "Beginning" To Recognize Drug Chains' Role In Healthcare - NACDS

NACDS has made progress in helping pharmaceutical manufacturers recognize drug store chains' role in healthcare, National Association of Chain Drug Stores Chairman Alan Levin told the association's annual meeting April 22 in Phoenix, Ariz.

HHS Privacy Reg Consent Process Will Be Clarified After Rules Take Effect

HHS plans to clarify prior consent requirements in the Health Insurance Portability and Accountability Act final privacy rule through future guidelines or modifications, the department said April 12.

Related Content

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts